-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 4th, the 2022 China Biopharmaceutical Innovation Cooperation Conference announced the "2022 China Biopharmaceutical Industry Value List" in Suzhou, and grandly released 9 sub-lists including small molecule innovative drugs, antibody drugs, innovative therapies, and service provide.
With its innovative capabilities of local research and development, as well as its high-quality, high-performance Chinese-made products and solutions produced locally, Bailinke was successfully selected and won the title of "Excellent Service Provider in the Biomedical Industr.
.
Wang Zhi, general manager of Bailinke, was invited to attend the award ceremo.
"2022 China Biopharmaceutical Industry Value List" is sponsored and sponsored by Wanyi Medical, Yiyun Technology and China Medical Research Institu.
, industry, and enterprise in-depth evaluation, and finally form the "2022 China Biomedical Industry Value Lis.
During the selection process of the "2022 China Biopharmaceutical Industry Value List", it has received high attention and active participation from professional research institutions, industry experts and scholars, entrepreneurs and industry colleagues, and has been highly prais.
The selection of Bailinke in the "2022 China Biopharmaceutical Industry Value List" further reflects the full recognition of Bailinke's high-quality development trend from all walks of life in the indust.
In this regard, .
Wang Zhi, the general manager of the company, said: "I am very honored to receive the honor of 'Excellent Service Provider in the Biomedical Industr.
This award is an encouragement to all colleagues who have been working hard at Balin.
As a new starting point, we will continue to shoulder the mission of 'empowering biotechnology and accessing infinite possibilities', deeply explore the development needs of the biopharmaceutical industry, and provide smarter, safer and more economical products and solutions for the production process of innovative biopharmaceutical therapi.
” Bailinke is a high-tech group enterprise that provides process solutions for life sciences, focusing on key process equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell therapy, gene therapy and other biological produc.
It is committed to continuously providing customers with high-quality innovative products and solutions, and creating an efficient, safe and competitive biopharmaceutical supply chain ecosyst.
Bailinke brings disposable bioprocessing solutions, protein chromatography products and the self-developed RNase-free technology at the booth F02 of the 6th China Biomedical Innovation Cooperation Conference held at the same ti.
Welcome guests from all walks of life to come and inqui.
With its innovative capabilities of local research and development, as well as its high-quality, high-performance Chinese-made products and solutions produced locally, Bailinke was successfully selected and won the title of "Excellent Service Provider in the Biomedical Industr.
.
Wang Zhi, general manager of Bailinke, was invited to attend the award ceremo.
"2022 China Biopharmaceutical Industry Value List" is sponsored and sponsored by Wanyi Medical, Yiyun Technology and China Medical Research Institu.
, industry, and enterprise in-depth evaluation, and finally form the "2022 China Biomedical Industry Value Lis.
During the selection process of the "2022 China Biopharmaceutical Industry Value List", it has received high attention and active participation from professional research institutions, industry experts and scholars, entrepreneurs and industry colleagues, and has been highly prais.
The selection of Bailinke in the "2022 China Biopharmaceutical Industry Value List" further reflects the full recognition of Bailinke's high-quality development trend from all walks of life in the indust.
In this regard, .
Wang Zhi, the general manager of the company, said: "I am very honored to receive the honor of 'Excellent Service Provider in the Biomedical Industr.
This award is an encouragement to all colleagues who have been working hard at Balin.
As a new starting point, we will continue to shoulder the mission of 'empowering biotechnology and accessing infinite possibilities', deeply explore the development needs of the biopharmaceutical industry, and provide smarter, safer and more economical products and solutions for the production process of innovative biopharmaceutical therapi.
” Bailinke is a high-tech group enterprise that provides process solutions for life sciences, focusing on key process equipment and consumables in the production of recombinant protein drugs, vaccines, antibody drugs, cell therapy, gene therapy and other biological produc.
It is committed to continuously providing customers with high-quality innovative products and solutions, and creating an efficient, safe and competitive biopharmaceutical supply chain ecosyst.
Bailinke brings disposable bioprocessing solutions, protein chromatography products and the self-developed RNase-free technology at the booth F02 of the 6th China Biomedical Innovation Cooperation Conference held at the same ti.
Welcome guests from all walks of life to come and inqui.
